MUB Medical Joins EWMA

MUB Medical joins EWMA – European Wound Management Association

We are honored to announce that MUB Medical Solutions has become a proud member of the European Wound Management Association (EWMA), a distinguished not-for-profit organization dedicated to advancing wound care excellence across Europe and beyond.

EWMA, established in 1991 as a registered charity in the UK, serves as a unifying force, connecting national wound management organizations, individuals, and groups passionate about wound care. At the core of EWMA’s mission lies the commitment to promote interdisciplinary and cost-effective wound care of the highest quality.

As an active member of EWMA, MUB Medical Solutions is poised to leverage this invaluable network to further our mission of making wound closure accessible, affordable, and efficient for all. We eagerly anticipate the opportunity to collaborate with experts within the EWMA community, sharing insights and expertise about our innovative solution, Sutrips.

Through our partnership with EWMA, we aim to amplify awareness about Sutrips and its transformative impact on wound closure. Together, we can drive progress, raise standards in wound management, and contribute to a healthier and more informed healthcare landscape.

We express our heartfelt gratitude to EWMA for this collaboration and look forward to a fruitful and impactful journey ahead.

To learn more about EWMA and its mission, please visit the EWMA website.

To learn more about Sutrips, please visit MUB Medical and follow our LinkedIn page.


Pre-clinical Trials Completed

Pre-clinical Trials Completed

We are thrilled to share a momentous achievement in our ongoing journey to transform wound closure with Sutrips.

In our recent independent clinical trial, Sutrips underwent test against the conventional interrupted suture technique.

The results speak volumes, and we couldn’t be more excited to reveal our progress!

This milestone takes us one step closer to realizing our mission: making wound closure universally accessible, affordable, and efficient.

For those eager to delve deeper into the clinical trial findings, we invite you to explore the full report, available for download. Please Click here.

Stay tuned as we continue to pioneer innovation in wound closure for a healthier world.


MUB Medical Secures Funding for Pre-clinical Trials

MUB Medical Secures Funding for Pre-clinical Trials

We are thrilled to announce that MUB Medical has received financing from Innovation Norway to conduct pre-clinical trials for Sutrips. This marks the third time that Innovation Norway has supported us financially, and we are incredibly grateful for their ongoing trust and belief in our vision.
With the backing of Innovation Norway, we are now focused on preparing for Sutrips’ global market introduction. We will actively engage with key industry players to explore potential collaborations for the successful launch of Sutrips.
It’s an exhilarating time for us, and we invite you to follow us on LinkedIn for more exciting updates. Stay tuned as we share the remarkable results of our proof of concept, which we recently completed.
Thank you for your unwavering support and enthusiasm as we work towards revolutionizing wound care with Sutrips! A simple Scandinavian solution for a complex global problem.


Introducing Sutrips

Introducing Sutrips-
Wound Closure with Adjustable Tension

We are thrilled to unveil the much-anticipated product introduction video for Sutrips, our game-changing suture tool that is set to transform the field of wound closure.

Sutrips: Precision in Every Stitch

Sutrips is not just another ordinary suture tool. It’s a breakthrough innovation that empowers healthcare professionals to achieve exceptional wound closure results. With Sutrips, we have harnessed the power of adjustable tension, allowing for a new level of precision and control in each stitch.

Advanced Technology, Optimal Healing

By providing the ability to apply different tension to each stitch, Sutrips offers unparalleled versatility and customization. This means healthcare professionals can adapt the tension to suit the specific needs of each wound, ensuring optimal healing outcomes. Whether it’s a deep laceration, a delicate incision, or any other wound type, Sutrips enables precise tension application for superior results.

Innovation at Its Finest

Sutrips represents a significant leap forward in wound closure technology. It eliminates the limitations of traditional suture tools by integrating adjustable tension capabilities into a user-friendly, all-in-one device. This not only streamlines the suturing process but also enhances patient comfort and minimizes complications.

Empowering Healthcare Professionals, Elevating Patient Care

We are proud to equip healthcare professionals with the tools they need to deliver the highest standard of care. Sutrips empowers them to achieve remarkable results, reduce procedural time, and optimize the healing journey for their patients. By harnessing the power of adjustable tension, Sutrips paves the way for advancements in wound closure techniques and improved patient outcomes.

Join Us on the Journey

We invite you to watch our product introduction video to witness the groundbreaking capabilities of Sutrips. Together, let’s revolutionize wound closure and make a lasting impact on the healthcare industry. Like, comment, and share this post to spread the word and join us on this exciting journey!

Explore also about Patent Issued in Indonesia.


Patent Issued in Indonesia


Securing Patent in Indonesia

We are thrilled to announce that MUB Medical Solutions has successfully secured a patent for our innovative wound closure solution, Sutrips, in Indonesia. With a population of over 270 million, Indonesia represents a significant and promising market for our product.

The patent grant in Indonesia further strengthens our position and allows us, along with our esteemed partners, to enforce protection rights for the sales and distribution of Sutrips in this important market. This milestone achievement underscores our commitment to delivering cutting-edge solutions and protecting our intellectual property.

“We are delighted to receive the patent for Sutrips in Indonesia,” said Ubbat Ocak, Founder of MUB Medical Solutions. “This achievement solidifies our market presence in the region and enables us to bring our innovative wound closure technology to healthcare professionals and patients in Indonesia.”

The Indonesian market holds immense potential due to its large population and growing healthcare needs. The patent provides us with a strong foundation to establish partnerships, expand market reach, and cater to the demands of healthcare providers seeking advanced wound closure solutions.

“We recognize the significance of the Indonesian market and the opportunities it presents,” stated Yasar Shaikh, CEO of MUB Medical Solutions. “Securing the patent for Sutrips in Indonesia empowers us to deliver superior quality products while upholding our commitment to intellectual property rights and ensuring the best outcomes for healthcare professionals and patients alike.”

MUB Medical Solutions remains dedicated to innovation, research, and development to continuously improve the wound closure process. The patent grant in Indonesia is a testament to our relentless pursuit of excellence and our determination to provide state-of-the-art solutions to healthcare providers globally.

As we continue to expand our market presence in Indonesia and other strategic regions, we invite healthcare professionals, distributors, and potential partners to join us on this exciting journey. Together, we can make a significant impact on the wound closure industry and enhance patient care.

Stay connected with MUB Medical Solutions through our website and social media channels for the latest updates on our products, partnerships, and advancements in the field of wound closure.

Great news: MUB Medical joins Aleap.